Oman vs Serbia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Oman
4 patients
in 2021
Serbia
3 patients
in 2019
Oman rank
115th
Serbia rank
117th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Oman
- Serbia
How they compare
Oman currently reports 4 patients against 3 patients in Serbia, a difference of 1 patients.
That makes Oman's figure about 1.3 times Serbia's.
The two have swapped places 7 times across 15 shared years of data; in 2005 it was Serbia ahead.
Oman ranks 115th and Serbia ranks 117th of 183 countries.
Across the 2 decades both report, Oman averaged higher in 1 and Serbia in 1.
Head to head by decade
| Decade | Oman | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9 patients | 7.2 patients | 1.8 patients | Oman |
| 2010s | 6.2 patients | 7.9 patients | 1.7 patients | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Oman or Serbia?
- Oman, at 4 patients against 3 patients in Serbia as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Oman and Serbia?
- 1 patients, with Oman ahead.
- How many years of comparable data are there for Oman and Serbia?
- 15 years are reported by both, from 2005 to 2019.
- How do Oman and Serbia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Oman ranks 115th and Serbia ranks 117th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.